Centessa Pharmaceuticals Plc ADR (CNTA) Stock Price, Quote & News

Company Profile

Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia. It also engages in the development of ORX142 which is in Phase I clinical trial for the treatme...

Industry: Biotechnology

Sector: Healthcare

Website: centessa.com

Address:

1 Ashley Road, 3rd Floor, Altrincham, United Kingdom

TwongStocks Jun. 17 at 7:06 PM

$CNTA Equity Corporate Actions Alert #2026 - 416 Information Regarding the Merger of Centessa Pharmaceuticals plc (CNTA) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-416 At a special meeting held on June 12, 2026, the shareholders of Centessa Pharmaceuticals plc (CNTA) approved the proposed merger with Eli Lilly and Company. The merger is tentatively scheduled to close prior to the market open on June 24, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on June 23, 2026. If the merger closes as anticipated, the stock will remain halted on the day of closing (June 24th) and will be suspended effective June 25, 2026.

0 · Reply

Mergerbrief Jun. 12 at 11:54 AM

$CNTA / $LLY – Shareholder Vote CNTA

0 · Reply

theoptionsplug Jun. 12 at 5:15 AM

THINGS TO WATCH, FRIDAY, 6/12/2026 👁️ $SPCX.X $LLY $CNTA $KLAC $SPY

1 · Reply

OpenOutcrier Apr. 29 at 8:04 PM

RECAP 4/29 Unusual Puts: $CNTA Jul 35 P $BMNR Jun 15 P $ONDS Dec 6 P $CCJ May29 85 P $ONDS Jun 8 P $WMT May01 125 P Live Breaking trading news www.openoutcrier.com

0 · Reply

StocktwitsNews Apr. 27 at 6:02 PM

Eli Lilly’s Been On An Acquisition Spree This Year – Here’s A Look At Its Major Deals $LLY $CNTA https://stocktwits.com/news/equity/markets/eli-lilly-acquisition-spree-this-year-look-at-its-major-deals/cZBNxaDRePo

0 · Reply

DonCorleone77 Apr. 13 at 4:48 AM

$CNTA Centessa downgraded to Hold from Buy at Truist Truist analyst Danielle Brill downgraded Centessa (CNTA) to Hold from Buy with a $38 price target after Eli Lilly (LLY) announced an agreement to acquire the company for $38 per share in cash plus a non-transferable contingent value right worth up to $9 per share.

0 · Reply

CapitalMonk Apr. 2 at 3:30 PM

$CNTA Price: $39.67 (-0.46%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±6.06% RSI: 78.5 | Momentum: Strong Momentum Volume: -60.0% vs avg Volatility: 10.45% Support: $25.06 | Resistance: $40.26 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

WycklyTrader Apr. 2 at 4:17 AM

KALV / PHVS potential big pharma acquisitions for hereditary angioedema (HAE) treatments. $APLS $DAWN $FOLD $EXAS $CNTA . BEP energy play.

0 · Reply

Spicy_Trade Apr. 2 at 4:09 AM

$CNTA Stock analysis https://youtu.be/DKJlY-cIfwo?si=d8brZd4Aq_Muj25T

0 · Reply

ZacksResearch Apr. 1 at 4:00 PM

$LLY just made a $7.8B move — and it’s not about obesity 👀 Lilly is acquiring $CNTA for $6.3B upfront (up to $7.8B with CVRs), adding a pipeline of OX2R agonists led by cleminorexton in mid-stage trials for narcolepsy and IH — a clear push to diversify beyond its GLP-1 dominance 💊 Centessa stock surged 44% on the news, while Lilly gained ~4%, signaling strong market approval of the strategy. Latest LLY news here 👉 https://www.zacks.com/stock/quote/LLY?cid=sm-stocktwits-0-quote_overview-oc-37620&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_37620

0 · Reply

Centessa gets FDA orphan drug designation for cleminorexton

Jun 1, 2026, 8:00 AM EDT - 18 days ago

Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development

ATNM

May 7, 2026, 8:00 AM EDT - 6 weeks ago

Centessa Pharmaceuticals Proxy statement: Proxy filing

May 5, 2026, 7:00 AM EDT - 6 weeks ago

Centessa Pharmaceuticals Quarterly report: Q1 2026

Apr 29, 2026, 8:00 AM EDT - 7 weeks ago

Centessa Pharmaceuticals Proxy statement: Proxy filing

2026-04-20T09:15:16.000Z - 2 months ago

Centessa downgraded to Equal Weight from Overweight at Wells Fargo

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Centessa Pharmaceuticals Proxy statement: Proxy filing

Apr 13, 2026, 8:00 AM EDT - 2 months ago

Centessa Pharmaceuticals Proxy statement: Proxy filing

2026-04-13T00:45:07.000Z - 2 months ago

Centessa downgraded to Hold from Buy at Truist

2026-04-01T16:00:43.000Z - 2 months ago

Centessa downgraded to Neutral from Buy at Guggenheim

2026-04-01T11:52:44.000Z - 2 months ago

Centessa downgraded to Market Perform from Outperform at LifeSci Capital

2026-04-01T10:17:54.000Z - 2 months ago

Centessa downgraded to Market Perform from Outperform at Leerink

Mar 31, 2026, 7:43 PM EDT - 2 months ago

Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly

LLY

2026-03-31T17:20:40.000Z - 2 months ago

Alkermes jumps 15% on renewed biotech M&A buzz, says Leerink

ALKS LLY

2026-03-31T16:45:17.000Z - 2 months ago

Centessa acquisition ‘may help rouse’ Alkermes shares, says RBC Capital

ALKS LLY

Mar 31, 2026, 12:24 PM EDT - 2 months ago

Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs

LLY

2026-03-31T16:11:15.000Z - 2 months ago

Alkermes jumps after Eli Lilly acquires peer Centessa

ALKS LLY

2026-03-31T16:09:59.000Z - 2 months ago

Centessa rises 44.8%

2026-03-31T15:10:58.000Z - 2 months ago

Centessa downgraded to Peer Perform from Outperform at Wolfe Research

Mar 31, 2026, 10:46 AM EDT - 2 months ago

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

LLY

2026-03-31T14:44:51.000Z - 2 months ago

Centessa downgraded to Neutral from Buy at B. Riley

2026-03-31T14:40:29.000Z - 2 months ago

Centessa rises 45.7%